Evaluation of the effect and duration of triamcinolone acetonide in the treatment of rheumatoid arthritis.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007596:Joints / Q000503:physiopathology; D007719:Knee Joint / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D012217:Rheumatoid Factor / Q000032:analysis; D013667:Technetium; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*
D010919:Placebos; D013667:Technetium; D012217:Rheumatoid Factor; D014222:Triamcinolone Acetonide